Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
2-7-1|Ce4Cli-Gy 3,INII2AB/1 6/71|1|92|Ce-144 chloride|11|kilobecquerels|Inhalation|3 Gy inhaled pH 5|3 (3 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-1-1|1|582|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-1|Ce4Cli-Gy 3,INII2AB/1 6/71|1|92|Ce-144 chloride|11|kilobecquerels|Inhalation|3 Gy inhaled pH 5|3 (3 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-1-2|1|724|Other deterministic changes|Whole body|n/a|
2-7-1|Ce4Cli-Gy 3,INII2AB/1 6/71|1|92|Ce-144 chloride|11|kilobecquerels|Inhalation|3 Gy inhaled pH 5|3 (3 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-1-3|1|914|Other deterministic changes|Lower respiratory system|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-1|2|621|Other deterministic changes|Whole body|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-2|2|621|Other deterministic changes|Whole body|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-3|2|621|Other deterministic changes|Whole body|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-4|2|621|Other deterministic changes|Whole body|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-5|2|628|Other deterministic changes|Whole body|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-6|2|677|Hyperplastic changes|Lower respiratory system|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-7|2|693|Other deterministic changes|Lower respiratory system|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-8|2|694|Neoplasia benign|Lower respiratory system|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-9|2|706|Neoplasia benign|Lower respiratory system|n/a|
2-7-2|Ce4Cli-Gy 11,INII2AB/2 1/72|1|92|Ce-144 chloride|40|kilobecquerels|Inhalation|11 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-2-10|2|758|Other deterministic changes|Lower respiratory system|n/a|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-1|3|327|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-2|3|343|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-3|3|431|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-4|3|442|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-5|3|459|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-6|3|470|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-7|3|470|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-8|3|579|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-9|3|592|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-10|3|641|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-11|3|679|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-3|Ce4Cli-Gy 16,INII2AB/11 5/74|1|92|Ce-144 chloride|59|kilobecquerels|Inhalation|16 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-3-12|3|752|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-1|4|206|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-2|4|352|Other deterministic changes|Whole body|n/a|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-3|4|379|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-4|4|389|Other deterministic changes|Lower respiratory system|n/a|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-5|4|410|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-6|4|423|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-7|4|439|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-8|4|440|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-9|4|451|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-10|4|473|Other deterministic changes|Lower respiratory system|n/a|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-11|4|473|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-12|4|477|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-13|4|478|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-14|4|497|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-15|4|503|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-16|4|506|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-17|4|515|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-18|4|530|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-19|4|570|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-20|4|579|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-21|4|579|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-22|4|579|Other deterministic changes|Lower respiratory system|n/a|
2-7-4|Ce4Cli-Gy 22.5,INII2AB/9+10 5/74|1|92|Ce-144 chloride|83|kilobecquerels|Inhalation|22.5 Gy inhaled pH 5|23 (23 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-4-23|4|626|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-1|5|51|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-2|5|222|Other deterministic changes|Whole body|n/a|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-3|5|339|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-4|5|339|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-5|5|404|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-6|5|451|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-7|5|469|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-8|5|542|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-9|5|600|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-10|5|600|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-11|5|672|Hyperplastic changes|Lower respiratory system|n/a|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-12|5|672|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 551 - sarcoma|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-13|5|692|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-14|5|697|Other deterministic changes|Whole body|n/a|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-15|5|757|Neoplasia benign|Lower respiratory system|n/a|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-16|5|792|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-17|5|796|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-5|Ce4Cli-Gy 33.5,INII2AB/1B+4 71-72|1|92|Ce-144 chloride|127|kilobecquerels|Inhalation|33.5 Gy inhaled pH 5|18 (18 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-5-18|5|859|Other deterministic changes|Whole body|n/a|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-1|6|51|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-2|6|82|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-3|6|286|Other deterministic changes|Whole body|n/a|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-4|6|430|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-5|6|438|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-6|6|519|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-7|6|519|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-8|6|627|Neoplasia benign|Lower respiratory system|n/a|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-9|6|715|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-10|6|721|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-6|Ce4Cli-Gy 42,INII2AB/5 2/73|1|92|Ce-144 chloride|163|kilobecquerels|Inhalation|42 Gy inhaled pH 5|11 (11 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-6-11|6|796|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-1|7|49|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-2|7|72|Neoplasia benign|Lower respiratory system,MA: 0000151 - skin|,MPATH: 443 - inverted squamous papilloma|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-3|7|75|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-4|7|79|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-5|7|79|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-6|7|218|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-7|7|221|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-8|7|282|Hyperplastic changes|Lower respiratory system|n/a|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-9|7|334|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-10|7|372|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-11|7|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-12|7|437|Hyperplastic changes|Lower respiratory system|n/a|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-13|7|445|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-14|7|520|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-15|7|548|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-16|7|570|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-17|7|602|Other deterministic changes|Whole body|n/a|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-18|7|607|Other deterministic changes|Whole body|n/a|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-19|7|652|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-20|7|652|Hyperplastic changes|Lower respiratory system|n/a|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-21|7|677|Hyperplastic changes|Lower respiratory system|n/a|
2-7-7|Ce4Cli-Gy 62,INII2AB/3+6 72-73|1|92|Ce-144 chloride|290|kilobecquerels|Inhalation|62 Gy inhaled pH 5|22 (22 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-7-22|7|705|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-1|8|447|Other deterministic changes|Whole body|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-2|8|560|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-3|8|590|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-4|8|602|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-5|8|623|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-6|8|625|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-7|8|646|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-8|8|666|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-9|8|671|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-10|8|677|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-11|8|677|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-12|8|679|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-13|8|682|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-14|8|695|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-15|8|706|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-16|8|712|Hyperplastic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-17|8|721|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-18|8|743|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-19|8|743|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-20|8|762|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-21|8|817|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-22|8|817|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-23|8|827|Hyperplastic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|1|92|Ce-144 chloride|55|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-24|8|827|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-1|8|447|Other deterministic changes|Whole body|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-2|8|560|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-3|8|590|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-4|8|602|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-5|8|623|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-6|8|625|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-7|8|646|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-8|8|666|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-9|8|671|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-10|8|677|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-11|8|677|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-12|8|679|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-13|8|682|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-14|8|695|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-15|8|706|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 270 - adenoma|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-16|8|712|Hyperplastic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-17|8|721|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-18|8|743|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-19|8|743|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-20|8|762|Preneoplastic changes|Lower respiratory system,MA: 0000422 - bronchiole|,MPATH: 171 - squamous metaplasia|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-21|8|817|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-22|8|817|Other deterministic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-23|8|827|Hyperplastic changes|Lower respiratory system|n/a|
2-7-8|Ce4Cli+-Gy 15,INII2AB/12+12 5/74|2|92|cerium|50|milligrams|Inhalation|inhaled|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-8-24|8|827|Other deterministic changes|Lower respiratory system|n/a|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-1|9|380|Other deterministic changes|Whole body|n/a|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-2|9|432|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-3|9|520|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-4|9|533|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-5|9|623|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-6|9|623|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-7|9|645|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-8|9|666|Neoplasia benign|Lower respiratory system|n/a|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-9|9|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-10|9|742|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-11|9|810|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|1|92|Ce-144 chloride|30|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-12|9|855|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-1|9|380|Other deterministic changes|Whole body|n/a|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-2|9|432|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-3|9|520|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-4|9|533|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-5|9|623|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-6|9|623|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-7|9|645|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-8|9|666|Neoplasia benign|Lower respiratory system|n/a|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-9|9|735|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-10|9|742|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-11|9|810|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-9|Ce4Cli+-Gy 22,INII2AB/7 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-9-12|9|855|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-1|10|374|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-2|10|430|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-3|10|469|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-4|10|485|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-5|10|508|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-6|10|527|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-7|10|659|Other deterministic changes|Whole body|n/a|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-8|10|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-9|10|688|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-10|10|808|Neoplasia malignant|Lower respiratory system|n/a|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-11|10|856|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|1|92|Ce-144 chloride|82|kilobecquerels|Inhalation|54 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-12|10|886|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-1|10|374|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-2|10|430|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-3|10|469|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-4|10|485|Neoplasia malignant|Bone among musculo-skeletal system diseases|metastatic|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-5|10|508|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-6|10|527|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-7|10|659|Other deterministic changes|Whole body|n/a|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-8|10|666|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-9|10|688|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-10|10|808|Neoplasia malignant|Lower respiratory system|n/a|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-11|10|856|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-10|Ce4Cli+-Gy 54,INII2AB/8 5/73|2|92|cerium|50|milligrams|Inhalation|inhaled|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-10-12|10|886|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-11|Ce4Oi-Gy 0.1,INII2AB/6 6/72|1|92|Ce-141 oxide|2|kilobecquerels|Inhalation|0.1 Gy inhaled pH 5|3 (3 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-11-1|11|710|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-11|Ce4Oi-Gy 0.1,INII2AB/6 6/72|1|92|Ce-141 oxide|2|kilobecquerels|Inhalation|0.1 Gy inhaled pH 5|3 (3 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-11-2|11|858|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-11|Ce4Oi-Gy 0.1,INII2AB/6 6/72|1|92|Ce-141 oxide|2|kilobecquerels|Inhalation|0.1 Gy inhaled pH 5|3 (3 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-11-3|11|858|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-1|12|411|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-2|12|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-3|12|569|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-4|12|582|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-5|12|583|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-6|12|587|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-7|12|587|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-8|12|592|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-9|12|592|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-10|12|605|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-11|12|605|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-12|12|607|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-13|12|622|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-14|12|692|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-15|12|712|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-16|12|740|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-17|12|743|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-18|12|750|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-19|12|767|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-20|12|769|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-21|12|775|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-22|12|782|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-23|12|787|Other deterministic changes|Lower respiratory system|n/a|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-24|12|832|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-25|12|848|Other deterministic changes|Lower respiratory system|n/a|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-26|12|848|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-27|12|848|Other deterministic changes|Lower respiratory system|n/a|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-28|12|850|Other deterministic changes|Lower respiratory system|n/a|
2-7-12|Ce4Oi-Gy 0.3,INII2AB/1+3 6/72|1|92|Ce-141 oxide|9|kilobecquerels|Inhalation|0.3 Gy inhaled pH 5|29 (29 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-12-29|12|850|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-1|13|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-2|13|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-3|13|513|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 242 - hemangiosarcoma|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-4|13|514|Other deterministic changes|Whole body|n/a|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-5|13|514|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-6|13|514|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-7|13|542|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-8|13|657|Other deterministic changes|Whole body|n/a|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-9|13|703|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-13|Ce4Oi-Gy 1.5,INII2AB/4 6/72|1|92|Ce-141 oxide|42|kilobecquerels|Inhalation|1.5 Gy inhaled pH 5|10 (10 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-13-10|13|730|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-1|14|322|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-2|14|435|Neoplasia benign|Lower respiratory system,MA: 0000436 - bronchus|,MPATH: 491 - polyp|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-3|14|567|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-4|14|585|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-5|14|585|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-6|14|587|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-7|14|648|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-8|14|655|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-9|14|658|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-10|14|772|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-11|14|772|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-14|Ce4Oi-Gy 3,INII2AB/5 6/72|1|92|Ce-141 oxide|84|kilobecquerels|Inhalation|3 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-14-12|14|859|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-1|15|539|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-2|15|587|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-3|15|592|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-4|15|603|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-5|15|612|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-6|15|684|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-7|15|807|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-8|15|807|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-9|15|819|Neoplasia malignant|Lower respiratory system|n/a|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-10|15|854|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 242 - hemangiosarcoma|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-11|15|870|Neoplasia malignant|Nervous system and special sense organs,MA: 0000016 - nervous system|benign,MPATH: 551 - sarcoma|
2-7-15|Ce4Oi-Gy 6,INII2AB/10 6/73|1|92|Ce-141 oxide|165|kilobecquerels|Inhalation|6 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-15-12|15|882|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-1|16|2|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-2|16|28|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-3|16|213|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-4|16|487|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-5|16|488|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-6|16|502|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-7|16|533|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-8|16|589|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 551 - sarcoma|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-9|16|606|Hyperplastic changes|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-10|16|624|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-11|16|628|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-12|16|648|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-13|16|654|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-14|16|654|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-15|16|681|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-16|16|707|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-17|16|778|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-18|16|811|Hyperplastic changes|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-19|16|826|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-20|16|878|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-21|16|887|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-22|16|893|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-23|16|921|Neoplasia malignant|Lower respiratory system|n/a|
2-7-16|Ce4Oi-Gy 15,INII2AB/8+9 6/73|1|92|Ce-141 oxide|418|kilobecquerels|Inhalation|15 Gy inhaled pH 5|24 (24 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-16-24|16|953|Neoplasia malignant|Thyroid and parathyroid glands among endocrine systems,MA: 0000129 - thyroid gland|,MPATH: 278 - follicular adenocarcinoma|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-1|17|362|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-2|17|392|Other deterministic changes|Whole body|n/a|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-3|17|473|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-4|17|476|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-5|17|491|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-6|17|494|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-7|17|507|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-8|17|625|Neoplasia malignant|Lower respiratory system|n/a|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-9|17|654|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-10|17|787|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-11|17|889|Neoplasia malignant|Lower respiratory system|n/a|
2-7-17|Ce4Oi-Gy 22,INII2AB/7 6/73|1|92|Ce-141 oxide|608|kilobecquerels|Inhalation|22 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-17-12|17|889|Neoplasia malignant|Lower respiratory system|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-1|18|3|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-2|18|23|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-3|18|48|Other deterministic changes|Whole body|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-4|18|287|Other deterministic changes|Whole body|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-5|18|289|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-6|18|289|Other deterministic changes|Whole body|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-7|18|289|Other deterministic changes|Whole body|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-8|18|289|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-9|18|291|Other deterministic changes|Whole body|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-10|18|297|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-11|18|302|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-12|18|345|Hyperplastic changes|Lower respiratory system|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-13|18|415|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-14|18|442|Other deterministic changes|Whole body|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-15|18|471|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-16|18|478|Neoplasia malignant|Other local manifestations and miscellaneus|metastatic|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-17|18|488|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-18|18|517|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-19|18|560|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-20|18|580|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-21|18|581|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-22|18|582|Inflammation and/or fibrotic diseases|Lower respiratory system,MA: 0000415 - lung|,MPATH: 215 - granulomatous inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-23|18|586|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-24|18|586|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-25|18|586|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-26|18|598|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-27|18|598|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-28|18|598|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-29|18|599|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-30|18|631|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-31|18|634|Hyperplastic changes|Lower respiratory system|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-32|18|658|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-33|18|663|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-34|18|664|Neoplasia benign|Lower respiratory system|n/a|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-35|18|850|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-18|Ce1Cli-Gy 1.2,INII2AB/1+3+4 7/73|1|92|Ce-141 chloride|42|kilobecquerels|Inhalation|1.2 Gy inhaled pH 5|36 (36 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-18-36|18|869|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-1|19|27|Other deterministic changes|Whole body|n/a|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-2|19|318|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-3|19|335|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-4|19|364|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-5|19|427|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-6|19|471|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-7|19|481|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-8|19|582|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-9|19|582|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-10|19|627|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-11|19|705|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-19|Ce1Cli-Gy 1.2,INII2AB/2 6/71|1|92|Ce-141 chloride|57|kilobecquerels|Inhalation|1.8 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-19-12|19|711|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-1|20|507|Neoplasia benign|Lower respiratory system|n/a|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-2|20|687|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-3|20|687|Other deterministic changes|Whole body|n/a|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-4|20|687|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-5|20|702|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-6|20|707|Other deterministic changes|Whole body|n/a|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-7|20|708|Other deterministic changes|Whole body|n/a|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-8|20|750|Neoplasia benign|Lower respiratory system|n/a|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-9|20|805|Other deterministic changes|Lower respiratory system|n/a|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-10|20|810|Other deterministic changes|Whole body|n/a|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-11|20|812|Other deterministic changes|Lower respiratory system|n/a|
2-7-20|YtCli-Gy 30,INII2AB/1 9/73|1|92|Y-90 chloride|129|kilobecquerels|Inhalation|30 Gy inhaled pH 5|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-20-12|20|812|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 214 - chronic inflammation|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-1|21|455|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-2|21|467|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-3|21|499|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-4|21|529|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-5|21|532|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-6|21|587|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-7|21|610|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-8|21|625|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-9|21|727|Other deterministic changes|Lower respiratory system|n/a|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-10|21|754|Other deterministic changes|Lower respiratory system|n/a|
2-7-21|Ce4Clmw-kBq 110,INJ1BG 9/73|1|92|Ce-144 chloride|110|kilobecquerels|Injection, intramuscular|IM Injection|11 (11 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-21-11|21|769|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-1|22|340|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-2|22|397|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-3|22|405|Other deterministic changes|Whole body|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-4|22|423|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-5|22|424|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-6|22|424|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-7|22|424|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-8|22|437|Other deterministic changes|Lower respiratory system|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-9|22|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-10|22|437|Other deterministic changes|Lower respiratory system|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-11|22|449|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-12|22|464|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-13|22|466|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-14|22|466|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-15|22|477|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-16|22|477|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-17|22|478|Other deterministic changes|Whole body|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-18|22|480|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-19|22|480|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-20|22|487|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-21|22|493|Other deterministic changes|Whole body|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-22|22|500|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-23|22|500|Other deterministic changes|Whole body|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-24|22|511|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-25|22|511|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-26|22|511|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-27|22|512|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-28|22|532|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-29|22|542|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-30|22|549|Inflammation and/or fibrotic diseases|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 213 - acute inflammation|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-31|22|559|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-32|22|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-33|22|578|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-34|22|584|Neoplasia malignant|Lower digestive tract,MA: 0000054 - peritoneal cavity|,MPATH: 365 - mesothelioma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-35|22|590|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-36|22|606|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-37|22|609|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-38|22|616|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-39|22|620|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-40|22|620|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-41|22|620|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-42|22|630|Neoplasia benign|Lower respiratory system|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-43|22|635|Neoplasia malignant|Lower respiratory system|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-44|22|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-45|22|655|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-46|22|667|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-47|22|683|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-48|22|714|Other deterministic changes|Lower respiratory system|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-49|22|719|Other deterministic changes|Lower respiratory system|n/a|
2-7-22|Ce4Clmw-kBq 155,INJ1BG 9/73|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|50 (50 in ERA)|Rat|Rat Wistar|Male|Young Adult|Lifespan study|2-7-22-50|22|725|Other deterministic changes|Lower respiratory system|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-1|23|324|Neoplasia benign|Integumentary system,MA: 0000146 - skin gland|benign,MPATH: 219 - adnexal and skin appendage tumor|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-2|23|385|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-3|23|392|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-4|23|428|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-5|23|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-6|23|435|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-7|23|435|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-8|23|438|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-9|23|449|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-10|23|478|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-11|23|519|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-12|23|519|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-13|23|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-14|23|548|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-15|23|553|Other deterministic changes|Lower respiratory system|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-16|23|554|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-17|23|554|Other deterministic changes|Lower respiratory system|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-18|23|571|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-19|23|571|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-20|23|577|Other deterministic changes|Lower respiratory system|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-21|23|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-22|23|589|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-23|23|590|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-24|23|591|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-25|23|592|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-26|23|592|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-27|23|592|Other deterministic changes|Lower respiratory system|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-28|23|602|Other deterministic changes|Lower respiratory system|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-29|23|609|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-30|23|609|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-31|23|612|Other deterministic changes|Lower respiratory system|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-32|23|613|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-33|23|619|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-34|23|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-35|23|647|Other deterministic changes|Lower respiratory system|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-36|23|657|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-37|23|659|Other deterministic changes|Lower respiratory system|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-38|23|714|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-39|23|721|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-23|Ce4Clm-kBq 155,INJ1BG 12/76|1|92|Ce-144 chloride|155|kilobecquerels|Injection, intramuscular|IM Injection|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-23-40|23|728|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-1|24|304|Other deterministic changes|Whole body|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-2|24|316|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-3|24|323|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-4|24|327|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-5|24|331|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-6|24|343|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-7|24|353|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-8|24|365|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-9|24|365|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-10|24|365|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-11|24|371|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-12|24|372|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-13|24|372|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-14|24|385|Neoplasia benign|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-15|24|385|Neoplasia benign|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-16|24|389|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-17|24|393|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-18|24|397|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-19|24|397|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-20|24|399|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-21|24|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-22|24|399|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-23|24|402|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-24|24|402|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-25|24|403|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-26|24|407|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-27|24|407|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-28|24|412|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-29|24|428|Other deterministic changes|Whole body|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-30|24|434|Hyperplastic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-31|24|449|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-32|24|449|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-33|24|450|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-34|24|457|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-35|24|459|Neoplasia benign|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-36|24|459|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-37|24|459|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-38|24|459|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-39|24|474|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-40|24|474|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-41|24|478|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-42|24|480|Other deterministic changes|Whole body|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-43|24|487|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-44|24|502|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-45|24|502|Other deterministic changes|Whole body|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-46|24|502|Other deterministic changes|Whole body|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-47|24|507|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-48|24|515|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-49|24|515|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-50|24|522|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-51|24|522|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-52|24|528|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-53|24|529|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-54|24|532|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-55|24|532|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-56|24|533|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-57|24|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-58|24|544|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-59|24|547|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-60|24|549|Other deterministic changes|Whole body|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-61|24|585|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-62|24|585|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-63|24|592|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-64|24|592|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-65|24|602|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-66|24|602|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-67|24|604|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-68|24|606|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-69|24|607|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-70|24|624|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-71|24|636|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-72|24|653|Other deterministic changes|Lower respiratory system|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-73|24|663|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-74|24|674|Other deterministic changes|Whole body|n/a|
2-7-24|Ce4Clm-kBq 215,INJ1BG1(3 groups) 72-74|1|92|Ce-144 chloride|215|kilobecquerels|Injection, intramuscular|IM Injection|75 (75 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-24-75|24|674|Other deterministic changes|Lower respiratory system|n/a|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-1|25|367|Changes due to an abnormal circulation|Bloodvessels among cardiovascular system|n/a|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-2|25|427|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-3|25|427|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-4|25|442|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-5|25|490|Other deterministic changes|Whole body|n/a|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-6|25|507|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-7|25|507|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-8|25|527|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 268 - adenocarcinoma|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-9|25|542|Other deterministic changes|Lower respiratory system|n/a|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-10|25|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-11|25|548|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-25|Ce4Clm-kBq 315,INJ1BG 3/72|1|92|Ce-144 chloride|315|kilobecquerels|Injection, intramuscular|IM Injection|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-25-12|25|572|Other deterministic changes|Whole body|n/a|
2-7-26|Ce4Clm-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Injection|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-26-1|26|388|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-26|Ce4Clm-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Injection|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-26-2|26|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-26|Ce4Clm-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Injection|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-26-3|26|450|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-26|Ce4Clm-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Injection|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-26-4|26|487|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-26|Ce4Clm-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Injection|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-26-5|26|542|Other deterministic changes|Whole body|n/a|
2-7-26|Ce4Clm-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Injection|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-26-6|26|570|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-26|Ce4Clm-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Injection|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-26-7|26|599|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-26|Ce4Clm-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Injection|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-26-8|26|624|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-1|27|527|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-2|27|647|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-3|27|687|Neoplasia benign|Lower respiratory system,MA: 0000415 - lung|,MPATH: 425 - leiomyoma|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-4|27|742|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-5|27|747|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-6|27|747|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-7|27|749|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-8|27|751|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-9|27|751|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-10|27|777|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-11|27|828|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-12|27|828|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-13|27|852|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-14|27|856|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-15|27|860|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-16|27|872|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-17|27|917|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-18|27|917|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-19|27|967|Other deterministic changes|Lower respiratory system|n/a|
2-7-27|Ce4Clmy-kBq 2.6,INJ1BG 3/77|1|5|Ce-144 chloride|2.6|kilobecquerels|Injection, intramuscular|IM Injection|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Lactation|Lifespan study|2-7-27-20|27|982|Other deterministic changes|Lower respiratory system|n/a|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-1|28|361|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-2|28|372|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-3|28|373|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-4|28|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-5|28|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-6|28|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-7|28|379|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-8|28|385|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-9|28|395|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-10|28|395|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-11|28|408|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-12|28|408|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-13|28|412|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-14|28|427|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-15|28|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-16|28|434|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-17|28|438|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-18|28|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-19|28|448|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-20|28|454|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-21|28|457|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-22|28|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-23|28|488|Other deterministic changes|Lower respiratory system|n/a|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-24|28|504|Other deterministic changes|Lower respiratory system|n/a|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-25|28|510|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-26|28|532|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-27|28|535|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-28|28|542|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-29|28|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-30|28|560|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-31|28|563|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-32|28|581|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-33|28|581|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-34|28|598|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-35|28|618|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-36|28|624|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-37|28|634|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-38|28|639|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-39|28|653|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-28|Ce4Cl-PB-kBq 185,INJ1BG 11/76|1|92|Ce-144 chloride|185|kilobecquerels|Injection, intramuscular|IM Inj.+ saline|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-28-40|28|692|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-1|29|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-2|29|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-3|29|471|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-4|29|560|Other deterministic changes|Lower respiratory system|n/a|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-5|29|605|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-6|29|606|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-7|29|634|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-8|29|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|2|92|endoxane|15|milligrams per kg animal|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-1|29|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|2|92|endoxane|15|milligrams per kg animal|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-2|29|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|2|92|endoxane|15|milligrams per kg animal|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-3|29|471|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|2|92|endoxane|15|milligrams per kg animal|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-4|29|560|Other deterministic changes|Lower respiratory system|n/a|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|2|92|endoxane|15|milligrams per kg animal|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-5|29|605|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|,MPATH: 549 - carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|2|92|endoxane|15|milligrams per kg animal|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-6|29|606|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|2|92|endoxane|15|milligrams per kg animal|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-7|29|634|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-29|Ce4Cl-EN-kBq 1600,INJ1BG 3/77|2|92|endoxane|15|milligrams per kg animal|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-29-8|29|724|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-1|30|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-2|30|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-3|30|450|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-4|30|471|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-5|30|584|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-6|30|619|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-7|30|647|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-8|30|716|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|2|92|imuran|1|milligrams per kg animal|Injection, intramuscular|IM inj.2 times/m|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-1|30|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|2|92|imuran|1|milligrams per kg animal|Injection, intramuscular|IM inj.2 times/m|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-2|30|444|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|2|92|imuran|1|milligrams per kg animal|Injection, intramuscular|IM inj.2 times/m|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-3|30|450|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|2|92|imuran|1|milligrams per kg animal|Injection, intramuscular|IM inj.2 times/m|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-4|30|471|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|2|92|imuran|1|milligrams per kg animal|Injection, intramuscular|IM inj.2 times/m|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-5|30|584|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|2|92|imuran|1|milligrams per kg animal|Injection, intramuscular|IM inj.2 times/m|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-6|30|619|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|2|92|imuran|1|milligrams per kg animal|Injection, intramuscular|IM inj.2 times/m|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-7|30|647|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-30|Ce4Cl-IM-kBq 1600,INJ1BG 3/77|2|92|imuran|1|milligrams per kg animal|Injection, intramuscular|IM inj.2 times/m|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-30-8|30|716|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-1|31|372|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-2|31|381|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-3|31|381|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-4|31|388|Other deterministic changes|Whole body|n/a|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-5|31|402|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-6|31|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-7|31|457|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-8|31|591|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-9|31|634|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|2|92|calcitar|1|Units|Injection, intramuscular|IM inj.2*/m|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-1|31|372|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|2|92|calcitar|1|Units|Injection, intramuscular|IM inj.2*/m|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-2|31|381|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|2|92|calcitar|1|Units|Injection, intramuscular|IM inj.2*/m|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-3|31|381|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|2|92|calcitar|1|Units|Injection, intramuscular|IM inj.2*/m|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-4|31|388|Other deterministic changes|Whole body|n/a|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|2|92|calcitar|1|Units|Injection, intramuscular|IM inj.2*/m|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-5|31|402|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|2|92|calcitar|1|Units|Injection, intramuscular|IM inj.2*/m|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-6|31|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|2|92|calcitar|1|Units|Injection, intramuscular|IM inj.2*/m|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-7|31|457|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|2|92|calcitar|1|Units|Injection, intramuscular|IM inj.2*/m|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-8|31|591|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-31|Ce4Cl-CA-kBq 1600,INJ1BG 3/77|2|92|calcitar|1|Units|Injection, intramuscular|IM inj.2*/m|9 (9 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-31-9|31|634|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-1|32|388|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-2|32|410|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-3|32|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-4|32|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-5|32|486|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-6|32|509|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-7|32|529|Neoplasia malignant|Lower respiratory system|n/a|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|1|92|Ce-144 chloride|1600|kilobecquerels|Injection, intramuscular|IM Inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-8|32|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|2|92|Am-241 (?chemical form)|9.25|kilobecquerels|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-1|32|388|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|2|92|Am-241 (?chemical form)|9.25|kilobecquerels|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-2|32|410|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|2|92|Am-241 (?chemical form)|9.25|kilobecquerels|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-3|32|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|2|92|Am-241 (?chemical form)|9.25|kilobecquerels|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-4|32|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|2|92|Am-241 (?chemical form)|9.25|kilobecquerels|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-5|32|486|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|2|92|Am-241 (?chemical form)|9.25|kilobecquerels|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-6|32|509|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|2|92|Am-241 (?chemical form)|9.25|kilobecquerels|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-7|32|529|Neoplasia malignant|Lower respiratory system|n/a|
2-7-32|Ce4Cl-Am-kBq 1600,INJ1BG 3/77|2|92|Am-241 (?chemical form)|9.25|kilobecquerels|Injection, intramuscular|IM inj.|8 (8 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-32-8|32|556|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-1|33|296|Other deterministic changes|Whole body|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-2|33|345|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-3|33|347|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-4|33|347|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-5|33|371|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-6|33|407|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-7|33|414|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-8|33|415|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-9|33|415|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-10|33|477|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-11|33|480|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-12|33|490|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-13|33|498|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-14|33|502|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-15|33|508|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-16|33|514|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-17|33|519|Other deterministic changes|Whole body|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-18|33|522|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-19|33|526|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-20|33|536|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-21|33|536|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-22|33|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-23|33|556|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-24|33|564|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-25|33|583|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-26|33|584|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-27|33|585|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-28|33|585|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-29|33|591|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-30|33|606|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-31|33|624|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-32|33|631|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-33|33|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-34|33|655|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-35|33|675|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-36|33|685|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-37|33|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-38|33|718|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 219 - adnexal and skin appendage tumor|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-39|33|718|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|1|92|Ce-144 chloride|1660|kilobecquerels|Injection, intramuscular|IM Inj.|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-40|33|750|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-1|33|296|Other deterministic changes|Whole body|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-2|33|345|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-3|33|347|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-4|33|347|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-5|33|371|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-6|33|407|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-7|33|414|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-8|33|415|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-9|33|415|Neoplasia malignant|Upper respiratory system,MA: 0000442 - upper respiratory tract|,MPATH: 218 - neoplasm|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-10|33|477|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-11|33|480|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-12|33|490|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-13|33|498|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-14|33|502|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-15|33|508|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-16|33|514|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-17|33|519|Other deterministic changes|Whole body|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-18|33|522|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-19|33|526|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-20|33|536|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-21|33|536|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-22|33|550|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-23|33|556|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-24|33|564|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-25|33|583|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-26|33|584|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-27|33|585|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-28|33|585|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-29|33|591|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-30|33|606|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-31|33|624|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-32|33|631|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-33|33|637|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-34|33|655|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-35|33|675|Other deterministic changes|Lower respiratory system|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-36|33|685|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-37|33|706|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-38|33|718|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 219 - adnexal and skin appendage tumor|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-39|33|718|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-33|Ce4Cl-IN-kBq 1660,INJ1BG 1/77|2|92|interferon||unit code not relevant|Injection, intramuscular|interferon +amputation|40 (40 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-33-40|33|750|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-1|34|436|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-2|34|436|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-3|34|455|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-4|34|455|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-5|34|455|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-6|34|490|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-7|34|493|Other deterministic changes|Lower respiratory system|n/a|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-8|34|510|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-9|34|520|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-10|34|521|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-11|34|521|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-12|34|545|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-13|34|566|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-14|34|569|Other deterministic changes|Lower respiratory system|n/a|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-15|34|569|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-16|34|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-17|34|590|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-18|34|590|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-19|34|619|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-20|34|674|Other deterministic changes|Lower respiratory system|n/a|
2-7-34|Ce4Cla-kBq 1.85,INJ1BG 12/76|1|92|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|21 (21 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-34-21|34|693|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-1|35|306|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-2|35|313|Neoplasia malignant|Urinary system,MA: 0002636 - lower urinary tract|,MPATH: 549 - carcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-3|35|497|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-4|35|504|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-5|35|514|Neoplasia malignant|Liver among hepato-pancreatic system diseases,MA: 0000358 - liver|,MPATH: 242 - hemangiosarcoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-6|35|557|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-7|35|572|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-8|35|574|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-9|35|575|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-10|35|587|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-11|35|587|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-12|35|595|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-13|35|620|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-14|35|669|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-15|35|669|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-16|35|675|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-17|35|681|Neoplasia malignant|Reproductive system,MA: 0000410 - seminal vesicle|,MPATH: 268 - adenocarcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-18|35|694|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-19|35|696|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-20|35|703|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-21|35|715|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-22|35|722|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-23|35|731|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-24|35|734|Neoplasia malignant|Bloodvessels among cardiovascular system|benign|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-25|35|744|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-26|35|751|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-27|35|752|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-28|35|753|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-29|35|757|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-30|35|757|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-31|35|759|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-32|35|767|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-33|35|767|Neoplasia malignant|Other local manifestations and miscellaneus|benign|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-34|35|771|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-35|35|781|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-36|35|793|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-37|35|793|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|benign,MPATH: 268 - adenocarcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-38|35|793|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-39|35|793|Neoplasia malignant|Adrenal gland  among endocrine systems,MA: 0000116 - adrenal gland|benign,MPATH: 549 - carcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-40|35|793|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-41|35|797|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-42|35|802|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-43|35|806|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-44|35|811|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-45|35|812|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-46|35|812|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-47|35|821|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-48|35|837|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-49|35|863|Neoplasia malignant|Reproductive system,MA: 0000411 - testis|benign,MPATH: 218 - neoplasm|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-50|35|871|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-51|35|873|Neoplasia malignant|Mammary gland,MA: 0000145 - mammary gland|,MPATH: 268 - adenocarcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-52|35|879|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-53|35|883|Neoplasia malignant|Pancreas among hepato-pancreatic system diseases,MA: 0000120 - pancreas|,MPATH: 268 - adenocarcinoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-54|35|883|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|benign,MPATH: 408 - soft tissue fibrosarcoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-55|35|883|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-56|35|883|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-57|35|895|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-58|35|895|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-59|35|896|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-60|35|901|Other deterministic changes|Lower respiratory system|n/a|
2-7-35|Ce4Clay-kBq 1.85,INJ1BG 10/75|1|5|Ce-144 chloride|1.85|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-35-61|35|901|Other deterministic changes|Lower respiratory system|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-1|36|271|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-2|36|295|Other deterministic changes|Lower respiratory system|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-3|36|334|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-4|36|344|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-5|36|355|Other deterministic changes|Lower respiratory system|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-6|36|359|Neoplasia malignant|Lower respiratory system|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-7|36|366|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-8|36|376|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-9|36|380|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-10|36|380|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-11|36|383|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-12|36|390|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-13|36|397|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-14|36|403|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-15|36|403|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-16|36|403|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-17|36|405|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-18|36|408|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-19|36|419|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-20|36|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-21|36|424|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-22|36|425|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-23|36|425|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-24|36|431|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-25|36|431|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-26|36|431|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-27|36|434|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-28|36|434|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-29|36|435|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-30|36|436|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-31|36|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-32|36|437|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-33|36|443|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-34|36|452|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-35|36|462|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-36|36|464|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-37|36|471|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-38|36|474|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-39|36|485|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-40|36|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-41|36|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-42|36|499|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-43|36|510|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-44|36|510|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-45|36|513|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-46|36|521|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-47|36|521|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-48|36|531|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-49|36|531|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-50|36|535|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-51|36|553|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-52|36|553|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-53|36|562|Other deterministic changes|Whole body|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-54|36|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-55|36|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-56|36|573|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-57|36|580|Other deterministic changes|Lower respiratory system|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-58|36|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-59|36|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-60|36|600|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-61|36|778|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-1|36|271|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-2|36|295|Other deterministic changes|Lower respiratory system|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-3|36|334|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-4|36|344|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-5|36|355|Other deterministic changes|Lower respiratory system|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-6|36|359|Neoplasia malignant|Lower respiratory system|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-7|36|366|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-8|36|376|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-9|36|380|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-10|36|380|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-11|36|383|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-12|36|390|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-13|36|397|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-14|36|403|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-15|36|403|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-16|36|403|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-17|36|405|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-18|36|408|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-19|36|419|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-20|36|423|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-21|36|424|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-22|36|425|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-23|36|425|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-24|36|431|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-25|36|431|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-26|36|431|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-27|36|434|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-28|36|434|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-29|36|435|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-30|36|436|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-31|36|437|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-32|36|437|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-33|36|443|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-34|36|452|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-35|36|462|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-36|36|464|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-37|36|471|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-38|36|474|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-39|36|485|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-40|36|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-41|36|493|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-42|36|499|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-43|36|510|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-44|36|510|Neoplasia malignant|Integumentary system,MA: 0000151 - skin|,MPATH: 446 - squamous cell carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-45|36|513|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-46|36|521|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-47|36|521|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-48|36|531|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-49|36|531|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-50|36|535|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-51|36|553|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-52|36|553|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-53|36|562|Other deterministic changes|Whole body|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-54|36|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-55|36|568|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-56|36|573|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-57|36|580|Other deterministic changes|Lower respiratory system|n/a|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-58|36|580|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-59|36|588|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-60|36|600|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-36|Ce1/4Cla-kBq 185,INJ1BG 6/76|2|92|Ce-144 chloride|296|kilobecquerels|Injection, intramaxillary|intramaxill.|61 (61 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-36-61|36|778|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-1|37|325|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-2|37|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-3|37|365|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-4|37|370|Other deterministic changes|Lower respiratory system|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-5|37|373|Other deterministic changes|Lower respiratory system|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-6|37|430|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-7|37|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-8|37|430|Other deterministic changes|Lower respiratory system|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-9|37|430|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-10|37|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-11|37|455|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-12|37|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-13|37|497|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-14|37|514|Other deterministic changes|Lower respiratory system|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-15|37|545|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-16|37|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-17|37|581|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-18|37|604|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-19|37|625|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|1|92|Ce-141 chloride|185|kilobecquerels|Injection, intramaxillary|Intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-20|37|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-1|37|325|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-2|37|357|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-3|37|365|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-4|37|370|Other deterministic changes|Lower respiratory system|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-5|37|373|Other deterministic changes|Lower respiratory system|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-6|37|430|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-7|37|430|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-8|37|430|Other deterministic changes|Lower respiratory system|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-9|37|430|Neoplasia malignant|Lower digestive tract,MA: 0000323 - gastrointestinal system|,MPATH: 551 - sarcoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-10|37|451|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-11|37|455|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-12|37|492|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-13|37|497|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-14|37|514|Other deterministic changes|Lower respiratory system|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-15|37|545|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-16|37|576|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-17|37|581|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-18|37|604|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-19|37|625|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-7-37|Ce4Cla-Am-Bq 185,INJ1BG 12/76|2|92|Am-241 (?chemical form)|13|kilobecquerels|Injection, intramaxillary|intramaxill.|20 (20 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-37-20|37|694|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-1|38|682|Other deterministic changes|Lower respiratory system|n/a|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-2|38|684|Other deterministic changes|Lower respiratory system|n/a|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-3|38|712|Neoplasia malignant|Bone among musculo-skeletal system diseases|n/a|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-4|38|726|Other deterministic changes|Lower respiratory system|n/a|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-5|38|733|Other deterministic changes|Lower respiratory system|n/a|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-6|38|733|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-7|38|733|Other deterministic changes|Lower respiratory system|n/a|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-8|38|750|Other deterministic changes|Lower respiratory system|n/a|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-9|38|750|Other deterministic changes|Lower respiratory system|n/a|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-10|38|800|Inflammation and/or fibrotic diseases|Musculo-skeletal system,MA: 0000011 - connective tissue|,MPATH: 212 - inflammation|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-11|38|852|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-12|38|862|Other deterministic changes|Lower respiratory system|n/a|
2-7-38|Ce4Cls-kBq 0.85,INJ1BG 1/76|1|92|Ce-141 chloride|0.74|kilobecquerels|Injection, intrasinusoid|Intrasinusal|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-38-13|38|862|Other deterministic changes|Lower respiratory system|n/a|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-1|39|487|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-2|39|606|Other deterministic changes|Whole body|n/a|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-3|39|713|Other deterministic changes|Lower respiratory system|n/a|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-4|39|733|Neoplasia malignant|Lymphatic vessels among cardiovascular system|benign|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-5|39|840|Neoplasia malignant|Spleen and thymus  among haematolymphatic system,MA: 0000141 - spleen|,MPATH: 242 - hemangiosarcoma|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-6|39|846|Neoplasia malignant|Other local manifestations and miscellaneus,MA: 0000003 - organ system|,MPATH: 408 - soft tissue fibrosarcoma|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-7|39|846|Other deterministic changes|Lower respiratory system|n/a|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-8|39|848|Other deterministic changes|Lower respiratory system|n/a|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-9|39|852|Neoplasia malignant|Kidney among urinary system diseases,MA: 0000368 - kidney|,MPATH: 549 - carcinoma|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-10|39|859|Other deterministic changes|Lower respiratory system|n/a|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-11|39|859|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 549 - carcinoma|
2-7-39|Ce4Cls-kBq 4.44,INJ1BG 1/76|1|92|Ce-141 chloride|4.44|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-39-12|39|862|Other deterministic changes|Lower respiratory system|n/a|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-1|40|464|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-2|40|466|Neoplasia systemic|Haematolymphatic system,MA: 0002434 - hematopoietic system|,MPATH: 513 - Lymphoid neoplasms|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-3|40|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-4|40|472|Neoplasia malignant|Other local manifestations and miscellaneus|n/a|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-5|40|472|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-6|40|482|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-7|40|497|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-8|40|517|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-9|40|532|Neoplasia malignant|Lower respiratory system,MA: 0000433 - pleura|,MPATH: 365 - mesothelioma|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-10|40|618|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 446 - squamous cell carcinoma|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-11|40|635|Other deterministic changes|Lower respiratory system|n/a|
2-7-40|Ce4Cls-kBq 18.5,INJ1BG 1/76|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-40-12|40|635|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 255 - adenoacanthoma|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-1|41|245|Other deterministic changes|Lower respiratory system|n/a|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-2|41|251|Other deterministic changes|Lower respiratory system|n/a|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-3|41|256|Other deterministic changes|Other local manifestations and miscellaneus|n/a|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-4|41|334|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-5|41|334|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-6|41|366|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-7|41|391|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-8|41|401|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-9|41|414|Other deterministic changes|Lower respiratory system|n/a|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-10|41|438|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-11|41|446|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-41|Ce4Cls-kBq 166,INJ1BG 5/74|1|92|Ce-141 chloride|166|kilobecquerels|Injection, intrasinusoid|Intrasinusal|12 (12 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-41-12|41|477|Neoplasia malignant|Lower respiratory system,MA: 0000415 - lung|,MPATH: 513 - Lymphoid neoplasms|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-1|42|391|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-2|42|414|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-3|42|442|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-4|42|458|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-5|42|502|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-6|42|522|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-7|42|526|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-8|42|554|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-9|42|563|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-10|42|596|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-11|42|631|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-12|42|639|Other deterministic changes|Lower respiratory system|n/a|
2-7-42|Ce4Cld-kBq 18.5,INJ1BG 5/74|1|92|Ce-141 chloride|18.5|kilobecquerels|Injection, intradental|Intradental|13 (13 in ERA)|Rat|Rat, Sprague-Dawley SPF|Male|Young Adult|Lifespan study|2-7-42-13|42|676|Other deterministic changes|Lower respiratory system|n/a|
